Molecular Diagnostics

In Other News

• Childrens’ Urinary MicroRNAs Predict Future Development of Heart or Kidney Diseases

• Clinical Germline Testing Evaluated for Pediatric Cancer Patients

• Genetic Risk of Inflammatory Bowel Disease Appears Distinct in African Americans

• ctDNA Provides Prognostic Clues in Advanced BRAF-Mutated Melanoma Cases

• Rapid Lateral Flow Assays Detect COVID-19 Variants and Differentiate COVID-19 from Other Respiratory Viral Diseases

• Elevated Plasma Levels of Glial Fibrillary Acidic Protein Indicate Increased Alzheimer’s Risk

• Pulse-Controlled Amplification Tested for Infectious Disease Diagnostics

• 22-Gene Genomic Classifier Validated in Recurrent Prostate Cancer Patients

• Plasma or Urine Liquid Biopsy Tests May Guide Colorectal Cancer Treatment

• Proteogenomic and Metabolomic Studies Characterize Human Glioblastoma

• Study Confirms Value of the MyProstateScore Urine Test for Prostate Cancer Screening

• Next Generation Sequencing Finds More Gene Mutations for Leukemia

• Exome Sequencing Identified Pathogenic Variants in Cerebral Palsy Patients

• Analysis of Cell-free DNA in the Blood May Replace Examination of Biopsy Specimens for Disease Diagnosis

• NanoString Technology Modernizes Liposarcoma Diagnostics

• TFP Inhibitor Levels Elevated in Bleeding Tendency Patients

• Prolonged Maternal Zika Viremia Evaluated for Adverse Perinatal Outcomes

• Early Plasma Biomarkers Discovered for Alzheimer's Disease

• TAP1 Gene Polymorphisms Associated with Recurrent Respiratory Papillomatosis

• Liquid Biopsy Allows Monitoring of COVID-19 Damage to Cells, Tissues, and Organs

• Blood Test Detects Early Colorectal Adenomas

• Precise Measurement of DNA Length Polymorphisms Used to Diagnose Acute Myeloid Leukemia

• Liquid Biopsy Predicts Colon Cancer Relapse Months Earlier